Skip to main content
OpenTrials

Clinical trial condition

Recurrent Breast Carcinoma

Explore clinical trials studying Recurrent Breast Carcinoma. Study availability and eligibility vary by location and protocol.

72 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Breast Carcinoma trial results

Completed

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

NCT01145430

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Columbia University/Herbert Irving Cancer Center New York, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT01281150

Conditions
Adult Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
  • UPMC-Magee Womens Hospital Pittsburgh, Pennsylvania, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions